The Winners of the 2019 Xconomy Awards San Diego Are…

Xconomy

The nominees and finalists for the first-ever Xconomy Awards San Diego were an impressive bunch, making it tough for our judges and the editors to pick the winners. 2019 WINNERS Big Idea Gene Yeo, University of California, San Diego.

San Diego Life Sciences Roundup: MEI Pharma, Turning Point, & More

Xconomy

It was a relatively quiet week in the San Diego life sciences community, but local companies and organizations continue working away. —MEI Pharma, a late-stage cancer drug developer, presented updated data from a Phase 1b study of its lead drug candidate, ME-401, which is designed to inhibit a molecular pathway called PI3K delta.

San Diego Life Sciences Roundup: MedCrypt, LunaDNA, Dynacure & More

Xconomy

Let’s catch up with the latest life sciences news in San Diego. “Patient data privacy has long been a concern, but the healthcare industry is just beginning to address patient safety risks presented by internet-connected healthcare technology,” Read more » Reprints | Share: UNDERWRITERS AND PARTNERS. — Cybersecurity company MedCrypt, which makes software to protect medical devices, raised a $5.3 million Series A funding round.

Back to the (Near) Future: Join Us for San Diego Life Sciences 2022

Xconomy

In 2010, Xconomy convened “San Diego Life Sciences 2030,” a séance with the soothsayers of San Diego as they gazed into the future at what the local life sciences landscape might look like 20 years from now.

Duchenne Advocates Start Casimir, Aiming to Capture Missing Data

Xconomy

In the midst of it all were parents who pushed hard and advocated like never before, even making public presentations to the FDA, under the agency’s new willingness to hear public and patient input. Three years ago, the FDA made one of the most polarizing decisions in its history.

ASCO Abstracts: Breast Cancer, Precision Treatments in the Spotlight

Xconomy

Data presented at the American Society of Clinical Oncology meeting each year can change medical practice and make or break companies whose drugs are under the microscope. The world’s biggest annual cancer conference is just around the corner.

New U.S. “Roadmap” Lays Out Routes to Accelerate Robotic Technologies

Xconomy

Christensen made his observations during a presentation at the 2016 Contextual Robotics Forum, a recent conference at UC San Diego focused this year on “new directions in human-machine interaction.”.

Agenda Posted for Net@50 on July 16 at MIT Media Lab

Xconomy

And a gala dinner at Café ArtScience will honor the internet’s pioneers and bring together past, present, and future technology and business leaders.

.Net 84

Bio Roundup: Pharma in D.C., Bristol-Cel in Trouble, Roche Gets A Spark

Xconomy

Bristol (NYSE: BMY ) and Celgene (NASDAQ: CELG ) have campaignned heavily, starting with a joint presentation by their CEOs at the J.P. Could a shareholder revolt doom the planned marriage of Bristol-Myers Squibb and Celgene?

“JK Told Me He Was Planning This”: A CRISPR Baby Q&A with Matt Porteus

Xconomy

After He’s presentation, two leading researchers, Robin. Last week, Chinese researcher He Jiankui stunned the world with his claim to have created the world’s first gene-edited humans. He said he had used CRISPR-Cas9 to change the DNA of the embryos of twin girls, to make them immune to HIV infection, then implanted them in their mother’s womb via in vitro fertilization. He announced on video the girls were born healthy.

California Accelerators Enroll Startups Targeting Cannabis Industry

Xconomy

On Monday, nine startups began a 16-week program at Canopy San Diego , a new accelerator program for seed-stage companies developing new technologies, products, and services to support the legal cannabis industry.

Tocagen Adopts “Seamless Pivotal Trial” for Brain Cancer Therapy

Xconomy

Yet San Diego-based Tocagen (NASDAQ: TOCA ) says five patients in a high-dose cohort of its gene therapy treatment Toca 511 and Toca FC are still alive after nearly 36 months.

Exosomes Head to Wall Street As Codiak Biosciences Lines Up IPO

Xconomy

The coming IPO for Codiak Biosciences will present a test case. Do Wall Street investors believe that exosomes, the tiny bubbles once thought to be just cellular garbage bins, may be the key to treating a slew of potential diseases?

Bio Roundup: Depression Drug Dashed, Peek at ASH, CRISPR Worry & More

Xconomy

We also bring you a few verses from the abstract , er, abstracts: Previews of results that will be presented more. The gene-editing technology CRISPR-Cas9 is opening up new research avenues all the time, such as giving drug developers a cheaper, faster way to knock out genes in tumor cells. Studies of CRISPR-Cas9 to treat human disease are about to start, too.

Bio Roundup: Lung Cancer Showdown, Gene Therapy Deals, IPO Busts

Xconomy

At one of the year’s big cancer meetings, investors, researchers, and many others will have a close eye on a group of presentations touting new lung cancer regimens that combine immunotherapies with other treatments.

Notes From the JPM ’18 Vortex: Gene Therapy’s Reckoning and Lonely Cabs

Xconomy

Morgan Healthcare conference in San Francisco winds down today, meaning the remaining stragglers are either presenting to half-empty rooms or headed back to colder climes. The annual J.P.

Virtual Physical Therapy Firms Reflexion and MindMaze Probe Markets

Xconomy

For most patients—and for many drug developers—healthcare reimbursement policies can present a daunting maze of restrictions and uncertainties.

Wind Startup Evokes Puerto Rico’s Plight, Wins EvoNexus Pitch Event

Xconomy

San Diego’s Uprise Energy won the audience vote for best presentation at EvoNexus Demo Day, with a pitch that highlighted how its mobile wind turbines could help alleviate the plight of Puerto Rico in the wake of Hurricane Maria’s apocalyptic devastation. The startup event drew more than 400 people to Qualcomm’s San Diego headquarters late Thursday. National blog main National top stories San Diego San Diego blog main San Diego top stories

Precision Steps: Can Loxo Drug Help Broaden Use of Cancer DNA Tests?

Xconomy

Cancer experts believe that the data the company is presenting this morning at the American Society of Clinical Oncology not only demonstrate the potential of one.

Help 77

Echo Labs Wins “Quick Pitch” Contest with Digital Hybrid Microscope

Xconomy

By popular acclaim, San Diego-based Echo Laboratories founder Eugene Cho claimed top honors, and a $15,000 check, for his two-minute presentation last week in the 10th annual “Quick Pitch” competition, hosted by San Diego’s Tech Coast Angels.

Connect Hands Out 8 Most Innovative New Product Awards

Xconomy

Connect, the San Diego nonprofit supporting local innovation and entrepreneurship, handed out its Most Innovative New Product Awards at a dinner last night in La Jolla—recognizing innovations that range from an inflatable satellite antenna to a mobile app for art museums. The list was winnowed to about 30 finalists who presented their products last month to a panel of judges seleecting the winner in each category.

All In One Place: A New Immuno-Oncology Trial Resource

Xconomy

We acknowledge that what we present here only scratches the surface of each trial. More than 100 years ago, New York bone surgeon William Coley began to suspect that bacterial infections might be improving the outlook for patients also suffering from cancer.

Organovo to Test “Patches” for Patients Awaiting Liver Transplants

Xconomy

San Diego-based Organovo (NASDAQ: ONVO ) said today it plans to use its 3D bio-printing technology to produce living human liver tissue “patches” that can be transplanted in patients with fatal liver disease. The conference is making a webcast of his presentation available here.

Sample 102

A16Z Bio Fund’s Pande Sees A.I. as Way to Ride Bio Innovation

Xconomy

In a presentation a few months ago at the firm’s annual a16z Summit , Pande argued that many aspects of biology (biochemical pathways, for example) have become so big, complicated, and messy that understanding the system is beyond what a human being can comprehend.

ASH Sneak Peeks: Novartis, Juno Update CAR-T Lymphoma Competition

Xconomy

But previews of the big data presentations are out today, yielding more insight into what promises to be the first major competition in CAR-T cell therapy: Treatments for people with non-Hodgkin lymphoma (NHL) who have run out of other options and likely have only a few months to live.

Bio Roundup: ASCO Abstracts, Migraine Drug Prices & “Blueprint” Fallout

Xconomy

But yeah, that happened to Loxo Oncology when it released data previews for its American Society for Clinical Oncology presentations; the meeting starts in two weeks in Chicago. There’s nothing abstract about a 20 percent jump in a company’s stock price. Wednesday was ASCO abstract day, and we’ll round up the headliners below, all with caveats that these early peeks are not peer-reviewed and could be updated in a couple weeks.

Ionis, Biogen Make History With FDA Nod for Spine Disease Drug

Xconomy

Patients with spinal muscular atrophy got an early Christmas present on Friday. The FDA approved nusinersen (Spinraza), making the drug the first-ever marketed treatment for the rare, potentially deadly genetic disorder.

Water Metering Startup Wins Vote for “Best Demo” at EvoNexus Event

Xconomy

A San Diego civil engineer who has developed an alternative technology for automating the measurement of water flow gave the best presentation at EvoNexus Fall Demo Day, an event that drew nearly 400 entrepreneurs, investors, and supporters late Thursday to Qualcomm’s corporate headquarters. Water Pigeon co-founder Sarp Sekeroglu got the most votes in a survey conducted immediately after six startups incubating at EvoNexus gave short presentations.

Agenda Posted for Xconomy’s Human Impact of Innovation on April 19

Xconomy

We have posted the agenda for Human Impact of Innovation , which happens on April 19 at The Illumina Theater at the Alexandria Torrey Pines in San Diego.

Tyler Jacks, Cancer Moonshot Panel Co-Chair, Discusses Roadmap

Xconomy

This week, a panel of 28 scientists presented the National Cancer Institute’s National Cancer Advisory Board a set of recommendations and national priorities for basic research, clinical trial practice, and drug development.

Mobileye Sets Safety-Based Rules of the Road for Self-Driving Tech

Xconomy

Defining just what constitutes “safe driving” for self-driving cars was the primary focus of a presentation Shashua delivered earlier this month at the Intel Capital Global Summit. It’s been a busy year for Jerusalem-based Mobileye since Intel (NASDAQ: INTC ) completed its $15.3-billion acquisition of the Israeli specialist in autonomous navigation technology. In a recent update, Mobileye co-founder and CTO Amnon Shashua said the company has almost doubled its workforce since the buyout.

CTO 44

Procrastinators’ Special! Save on 4/19 Human Impact of Innovation

Xconomy

We’re hosting an afternoon of insightful presentations and candid chats about some innovations that are making the biggest impact on human lives. Our program includes leading innovators, startup founders, investors, scientists, and CEOs from San.

Uber Suspends Driverless Testing After Fatal Accident in Arizona

Xconomy

The ride-hailing giant has suspended testing on driverless cars in Arizona, Pittsburgh, San Francisco, and Toronto, according to the New York Times. The inevitable has happened. An autonomous Uber car hit a pedestrian in Tempe, AZ, and caused her death.

Esports Startup Cayke Wins Audience Vote at EvoNexus Demo Day

Xconomy

Cayke, a San Diego startup that has developed video editing software to automate the process of creating GIFs and highlight clips from long-running video game streams, was the top vote-getter of seven startups that presented at the EvoNexus Spring Demo Day.

At Big Hemophilia Meeting, More Data, and Promise, For Gene Therapy

Xconomy

With that, here are the latest updates from the gene therapy players to present at the WFH’s meeting this week.